Our Clients

Clinilabs is a niche CRO that provides early phase and specialty clinical drug development services to industry.  We focus on Phase I and Phase IIa studies that prepare development candidates to move forward into Phase III pivotal trials.  Working within this niche, Clinilabs adds value to clinical drug development programs by executing studies that enable clients to make sound decisions regarding the viability of new drug candidates. Our goal is to move acceptable candidates forward swiftly, and abandon failures early.
 
As a niche provider, Clinilabs offers project plans and teams that are scaled to deliver studies that are executed efficiently with an unparalleled level of personalized service.  Our senior managers are actively involved in every project, every day.
 
Scaling service to the needs of the project enables Clinilabs to offer competitive pricing.  That is one of the reasons that many big pharma companies and CROs have identified us as their service provider of choice.  Working directly with pharma, we help assess a large number of compounds quickly and efficiently, maximizing return on investment. Working with larger CROs, our work under their skillful management helps the CRO client win large Phase II and III sponsored trials.
 
Clinilabs also provides specialty drug development services, primarily in the CNS and cardiovascular therapeutic areas.  These services include data acquisition and processing using specialized biomedical devices such as EEG, PSG, and ECG machines.